BEAM NASDAQ
Beam Therapeutics Inc.
1W: +5.2%
1M: -5.7%
3M: +16.8%
YTD: +12.3%
1Y: +64.0%
3Y: -10.5%
5Y: -61.7%
$30.47
+0.69 (+2.32%)
Pre-Market: $30.20 (-0.27, -0.89%)
Weekly Expected Move ±11.8%
$22
$26
$29
$33
$36
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026294
Institutions Holding
+14 vs prior
75.8%
Ownership
-16.12%
48
New
83
Increased
118
Reduced
66
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Evans John M. | officer: ceo | S-Sale | 30,078 | $24.58 | $739K | Filing |
| 2026-04-01 | Ciaramella Giuseppe | officer: president | S-Sale | 11,810 | $24.58 | $290K | Filing |
| 2026-04-01 | Bellon Christine | officer: chief legal officer | S-Sale | 5,956 | $24.58 | $146K | Filing |
| 2026-04-01 | Cavanagh Bethany J | officer: svp, finance and treasurer | S-Sale | 3,242 | $24.58 | $80K | Filing |
| 2026-04-01 | Simon Amy | officer: chief medical officer | S-Sale | 6,700 | $24.58 | $165K | Filing |
| 2026-03-31 | Bellon Christine | officer: chief legal officer | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2026-03-31 | Evans John M. | officer: ceo | A-Grant/Award | 90,000 | $— | $0 | Filing |
| 2026-03-31 | Evans John M. | officer: ceo | S-Sale | 25,000 | $22.76 | $569K | Filing |
| 2026-03-30 | Evans John M. | officer: ceo | S-Sale | 25,000 | $22.37 | $559K | Filing |
| 2026-02-24 | Ciaramella Giuseppe | officer: president | S-Sale | 35,000 | $32.00 | $1.1M | Filing |
| 2026-01-30 | Evans John M. | officer: ceo | S-Sale | 2,906 | $29.00 | $84K | Filing |
| 2026-01-30 | Evans John M. | officer: ceo | S-Sale | 22,094 | $28.27 | $625K | Filing |
| 2026-01-29 | Evans John M. | officer: ceo | S-Sale | 8,667 | $29.74 | $258K | Filing |
| 2026-01-29 | Evans John M. | officer: ceo | S-Sale | 16,333 | $29.19 | $477K | Filing |
| 2026-01-22 | Cavanagh Bethany J | officer: svp, finance and treasurer | S-Sale | 6,198 | $35.00 | $217K | Filing |
| 2026-01-22 | Bellon Christine | officer: chief legal officer | S-Sale | 1,371 | $34.00 | $47K | Filing |
| 2026-01-20 | Cavanagh Bethany J | officer: svp, finance and treasurer | S-Sale | 3,034 | $30.12 | $91K | Filing |
| 2026-01-15 | Bellon Christine | officer: chief legal officer | S-Sale | 559 | $35.40 | $20K | Filing |
| 2026-01-15 | Bellon Christine | officer: chief legal officer | S-Sale | 15,959 | $34.72 | $554K | Filing |
| 2026-01-15 | Bellon Christine | officer: chief legal officer | S-Sale | 2,111 | $33.62 | $71K | Filing |
| 2025-12-31 | Simon Amy | officer: chief medical officer | A-Grant/Award | 12,500 | $— | $0 | Filing |
| 2025-12-31 | Emany Sravan Kumar | officer: chief financial officer | S-Sale | 6,294 | $27.10 | $171K | Filing |
| 2025-12-31 | Bellon Christine | officer: chief legal officer | S-Sale | 1,254 | $27.10 | $34K | Filing |
| 2025-10-27 | FMR LLC | 10% owner | S-Sale | 459 | $26.68 | $12K | Filing |
| 2025-10-06 | FMR LLC | 10% owner | G-Gift | 1,232,434 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 12,452,199 | $297M | +543,061 | 2026-03-31 | Filing |
| ARK Investment Management LLC | 12,133,433 | $289M | -333,756 | 2026-03-31 | Filing |
| FARALLON CAPITAL MANAGEMENT LLC | 10,134,696 | $242M | +71,585 | 2026-03-31 | Filing |
| BlackRock, Inc. | 8,487,569 | $202M | +37,387 | 2026-03-31 | Filing |
| STATE STREET CORP | 5,699,265 | $136M | +470,736 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,570,797 | $109M | +4,570,797 | 2026-03-31 | Filing |
| ARCH Venture Management, LLC | 4,540,132 | $108M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,377,374 | $104M | +4,377,374 | 2026-03-31 | Filing |
| Amova Asset Management Americas, Inc. | 3,825,585 | $91M | -583,715 | 2026-03-31 | Filing |
| Sumitomo Mitsui Trust Group, Inc. | 3,825,585 | $91M | -583,715 | 2026-03-31 | Filing |
| Kynam Capital Management, LP | 3,682,185 | $88M | +1,241,971 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,418,592 | $58M | +66,684 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,154,575 | $51M | +206,696 | 2026-03-31 | Filing |
| UBS AM, a distinct business unit of UBS | 1,653,714 | $39M | -58,645 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 1,446,375 | $34M | +1,446,375 | 2026-03-31 | Filing |
| Redmile Group, LLC | 1,237,659 | $29M | -48,200 | 2026-03-31 | Filing |
| Qube Research & Technologies Ltd | 1,084,768 | $26M | +685,109 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,005,743 | $24M | +483,107 | 2026-03-31 | Filing |
| UBS Group AG | 826,061 | $20M | -147,782 | 2026-03-31 | Filing |
| NORTHERN TRUST CORP | 825,580 | $20M | +16,633 | 2026-03-31 | Filing |